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Abstract
Introduction: Adrenal incidentaloma can be described as adrenal lesions that are incidentally
diagnosed during abdominal laparotomy or any abdominal screening without prior suspicion of
adrenal disease. It is important to diagnose adrenal lesions to learn if they are hormonally active or
malignant. The most common clinical sign of pheochromocytoma is sustained or paroxysmal
hypertension, and the most common symptoms are headache, excessive truncal sweating, and
palpitation. In some cases, the clinical symptoms are not clear. Roughly 70% of adrenal
incidentalomas are non-functional. A small group of 5–7% of the functional ones (30%) may exist
as pheochromocytoma. Ten percent of pheochromocytoma cases are diagnosed incidentally during
computed tomography (CT) or magnetic resonance imaging (MRI) screenings for other reasons.
The most frequent symptom of the pheochromocytoma is hypertension, and 90–100% of cases
exhibit it. The literature indicates that incidental pheochromocytoma cases that are smaller than 1
cm have no clinical symptoms. Rarely, some large pheochromocytoma cases do not show any
clinical symptoms, and it is difficult to diagnose very small ones.
Case presentation: A 45-year-old male patient experienced an epigastric ache and distended
stomach for 7 years. The serum cortisol level was 19.2 ng/dL (normal range: 5–20 ng/dL), and
urinary free cortisol excretion was 25.00 µg/24 h (normal range:10.00–100.00 µg/24 h). The serum
basal level of adrenocorticotropic hormone (ACTH) was 21 pg/mL (normal range: 9 to 52 pg/mL).
Plasma cortisol was under 1.00 µg/dL after low dose (1 mg) overnight dexamethasone suppression
test. 24 hours urinary catecholamines level were vanil mandilic acid (VMA) 8.90 mg/day (normal
range, 3 to 90 mg/day), metanefrin 330 µg/day (normal range, 52 to 341 µg/day), epinefrin 13 µg/
day (normal range, 2 to 24 µg/day), norepinefrin 41 µg/day (normal range; 15 to 100 µg/day). During
abdominal ultrasonography (USG), a tumor was diagnosed in the right perirenal space. A regular-
shaped mass (dimension 36 × 35 × 35 mm) with a homogeneous and solid structure was diagnosed
in CT. The density of the mass was 80 Hounsfield units (HU) in postcontrast CT. The patient was
given a diagnosis of a non-functional adrenal incidental lesion, underwent a right adrenalectomy.
Histopathological data correlated with pheochromocytoma as well
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Conclusion: Pheochromocytoma can be diagnosed by establishing an increase in catecholamines
and metabolites in the plasma and urine. The level of catecholamines and metabolites in the plasma
and urine provide 95% of the evidence of the disease. Because the dimensions of the lesion were
large and the HU was very clear, the patient was underwent surrenalectomy. During laboratory
investigation, there was no evidence of abnormality; we, therefore, think that these cases can be
named sublaboratory pheochromocytoma.
Introduction
Adrenal incidentaloma can be described as adrenal
lesions that are incidentally diagnosed during abdominal
laparotomy or any abdominal screening without prior
suspicion of adrenal disease. This definition does not
include adrenal lesions that are diagnosed for oncological
metastasis. In the last 30 years, case diagnosis of adrenal
incidentaloma increased about 20 times because of tech-
nological development. It is important to diagnose adre-
nal lesions if the lesions are hormonally active or
malignant. The number of adrenal incidental cases
increase with age and application technique. Statistical
autopsy data suggests that these lesions occur in 1% of
people at age 30, but 7% at age 70 with no difference in
gender [1].
Pheochromocytoma is a tumoral disease that originates
from chromaffin cells in the sympathoadrenal system.
These tumors secrete epinephrine, norepinephrine, and in
some cases, dopamine and catecholamines. They secrete
other active peptides and cause symptoms of hyperten-
sion. Because pheochromocytoma is a rare disease, it is
present in only 0.1–0.2% of hypertension patients.
Although there is no difference in age or gender, occur-
rence increases in the 4th and 5th decades. Most pheo-
chromocytoma cases localize to the abdomen (90%), and
90% of abdomen-localized cases are in the adrenal glan-
dulas. The most common clinical sign of pheochromocy-
toma is a sustained or paroxysmal hypertension, and the
most common symptoms are headache, excessive truncal
sweating, and palpitation. Angina pectoris, abdominal
pain, queasiness, anxiety, and paleness are other symp-
toms of it as well. In some cases, clinical symptoms are
not clear until they are diagnosed incidentally during
computed tomography (CT) or magnetic resonance imag-
ing (MRI) [2,3].
Roughly 70% of adrenal incidentalomas are non-func-
tional. A small group of 5–7% of the functional ones
(30%) may exist as pheochromocytomas [4]. We review
the literature because our case had no preoperative clini-
cal or laboratory findings and was diagnosed postopera-
tively with a pathologic investigation.
Case
Case presentation
A 45-year-old male patient experienced an epigastric ache
and distended stomach for 7 years. During abdominal
ultrasonography (USG), a tumor was diagnosed in the
right suprarenal fossa. He did not use any drugs and there
was no characteristic of past medical and family illness
history. He was 1.74 cm and weighted 81 kg, with a body
mass index (BMI) of 26.5 kg/m2. His right hand tension
arteriel was 110/70 mmHg and his left hand tension arte-
rial was 115/70 mmHg; when standing, these values were
110/70 and 110/70 mmHg, respectively. Heart rate was
80 beats/minute, and no pathologic data was found in the
system examination. The laboratory data showed that
hemogram and urine findings were normal. His lipid pro-
file was normal. Other findings were as in Table 1.
Plasma cortisol was under 1.00 µg/dL after low dose (1
mg) overnight dexamethasone suppression test. 24 hours
urinary catecholamines level were vanil mandilic acid
(VMA) 8.90 mg/day (normal range, 3 to 90 mg/day),
metanefrin 330 µg/day (normal range, 52 to 341 µg/day),
epinefrin 13 µg/day (normal range, 2 to 24 µg/day), nore-
pinefrin 41 µg/day (normal range; 15 to 100 µg/day).
Hormonal levels were as in Table 2.
Abdominal USG
There was a 34 × 26 mm solid lesion in the right perirenal
space.
Table 1: Laboratory findings.
Levels Normal Range
Glucose 87 mg/Dl 70 to 100 mg/dL
BUN 20 mg/dL 7 to 18 mg/dL
Creatinine 0.9 mg/dL 0 to 1.3 mg/dL
Na 144 mmol/L 136 to 145 mmol/L
K+ 4 mmol/L 3.5 to 5.5 mmol/L
Ca+2 9.6 mg/dL 8.5 to 10.1 mg/dL
Cl 96 mmol/L 96 to 110 mmol/L
P 4.7 mg/dL 2.5 to 4.9 mg/dL
AST 13 U/L IU/L 15 to 37 IU/L
ALT 33 U/L 30 to 65 IU/LCases Journal 2008, 1:10 http://www.casesjournal.com/content/1/1/10
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Abdominal CT
Liver parenchyma was homogeneous. In the right lobe of
the liver, there was a two millimeter subcapsular calcifica-
tion. A regular-shaped mass (dimension 36 × 35 × 35
mm) with a homogeneous and solid structure was diag-
nosed at the right suprarenal fossa. The density of the
mass was 80 Hounsfield units (HU) in postcontrast CT
and 40 HU without contrast CT [Fig. 1].
After all these examinations, the patient was given a diag-
nosis of a non-functional adrenal incidental lesion.
Because it was 80 HU in contrast CT, 40 HU without con-
trast CT, and 36 × 35 × 35 mm, the patient underwent a
right adrenalectomy [Fig. 2]. There were no clinical prob-
lems during, before, or after the surgery. The pathology
examination confirmed the mass as being pheochromocy-
toma [Fig 3]. The patient was discharged after 5 days.
Discussion
The number of incidentally found adrenal lesions is grow-
ing. The most important problem in appraising adrenal
incidental cases is diagnosing the lesion as benign or
malignant. To distinguish malign and benign lesions,
screening methods must be used. CT is an ideal screening
method for the adrenal glandula and the most helpful
technique for distinguishing cysts, bleedings, and myelol-
ipomas. On the other hand, MRI is successful in distin-
guishing adrenal adenomas, carcinomas, and metastatic
masses. But CT has gained widespread acceptance as the
technique of choice for distinguishing between adrenal
adenomas and metastasis [5].
Adenomas frequently contain sufficient intracytoplasmic
fat to produce lower attenuation values. With an increas-
ing proportion of lipid mass, the density will be lower.
Although the lipid proportion is high in benign cases, it is
lower in malignant ones. No adrenal malignancy with a
density of 0 HU has been reported in the literature. It is
suggested that 4–20 HU density cases must be suspicious
Table 2: Hormonal levels
Hormonal Tests Levels Normal Range
TSH 1.53 µIU/mL 0.4 to 4.0 µIU/mL
LH 8.97 IU/L 3.6 to 17.1 IU/L
PRL 8.74 ng/mL 1.6 to 18.8 ng/mL
Insulin 5.75 µU/ml 3 to 20 µU/ml
PTH 8.74 pg/ml 7 to 11 pg/ml
Calcitonin 3.2 ng/L < 8 ng/L
Total testosterone 332 ng/dl 265 to 800 ng/dl
Plasma aldosterone 11 ng/dl 5 to 20 ng/dl
DHEA-S 214 µg/dl 59 to 492 µg/dL
Cortisol 19.2 ng/dL 5–20 ng/dL
Urinary free cortisol excretion 25.00 µg/24 h 10.00–100.00 µg/24 h
Serum basal level of ACTH 21 pg/mL 9 to 52 pg/mL
Mass in Abdominal CT Figure 1
Mass in Abdominal CT. Mass in intraoperative view Figure 2
Mass in intraoperative view.Cases Journal 2008, 1:10 http://www.casesjournal.com/content/1/1/10
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and patients in these cases undergo MRI. The cases in
which the density is higher than 20 HU are rated as
malign in some other studies [6]. In some benign cases
(especially acute phase bleeded), tomogrophic density is
very high. Pheochromocytomas are often well-defined
masses with attenuation values similar to those of muscle
tissue, measuring approximately 30–40 HU. The density
of the mass in our case was 80 HU in postcontrast CT and
40 HU without contrast CT.
The dimensions of lesion and a history of cancer are
important factors for distinguishing whether masses are
benign or not. While the carcinoma prevalence is 2 % for
the masses smaller than 4 cm, it is 6 % for the ones 4–6
cm and 25 % for those bigger than 6 cm. It is impossible
to morphologically distinguish adrenal metastases from
benign masses. The most reliable technique for distin-
guishing these two masses involves conducting a percutan
biopsy after elimination of the diagnosis of pheochromo-
cytoma. If the mass is pheochromocytoma, percutan
biopsy will cause a hypertension crisis. Biopsy is not an
adequate technique for distinguishing adrenocortical ade-
nomas and adrenocortical carcinomas [7]. While our
patient's CT investigation density was high, he underwent
surgery since the biopsy is invasive. We did not perform a
biopsy for the case.
The second important question in adrenal incidentaloma
is whether a lesion is functional or not. No functional
scanning is needed for myelolipoma and adrenal cysts,
which were diagnosed with screening methods alone.
According to the increase in the sensitivity of the
endocronologic tests used for differentiation diagnosis,
the prevalence of the subclinical syndrome and/or a silent
preclinical one is increased in these cases.
About 5–10 % of the adrenal incidental cases are subclin-
ical instances of Cushing syndrome. In all cases, Cushing
screening should be conducted with a 1 mgr Dexameta-
zone test. In this test, the limit for the pressured plasma
cortizol level is 1.8 µg/dL [8]. In our cases, there was sup-
pression after 1 mgr Dexametasone suppression. Free cor-
tizol levels in urine were normal after 24 hours, and so we
concluded that there was no pathology in glucocorticoid
function.
The level of the plasma potassium and renin-aldosterone
must be checked in hypertensioned adrenal incidental
cases. If the level of renin-aldosterone activity is greater
than 30 and the level of plasma aldosterone is higher than
20 ng/dl, there is an autonomic aldosterone secretion.
Roughly 80% of the primary aldosteronism are adenomas
and 1% of the cases are adrenocortical carcinomas. In
cases of adrenocortical adenoma with primer aldos-
teronism, the dimensions of the adenomas are typically
small [9]. Because there was no arterial hypertension in
our case and the level of aldosterone was normal, we did
not attribute diagnosis to an increase of mineralocorticoid
function.
Tumors producing androgens are rare. They may be malig-
nant or benign, and clinically, they have virilization
effects. DHEA-S provides the most important evidence for
the secretion of adrenal androgen. The level of DHEA-S
should be measured in adrenal incidentaloma cases.
There was no increase in androgen function due to the
lack of hyperandrogenic findings, and the levels of DHEA-
S were normal in our case.
Pheochromocytoma is a rare catecholamine secreting
tumor derived from chromaffin cells. It is thought that 5–
7 % of functional adrenal incidental masses may be phe-
ochromocytomas. Although pheochromocytoma is not
one of the main causes of hypertension, it will be fatal if
not controlled. About 10 % of pheochromocytoma cases
are diagnosed incidentally during CT or MRI that are
screened for other reasons [10]. Fifty percent of cases are
diagnosed by autopsy, and this shows that the disease is
seen frequently as well. Sometimes, prediagnosed pheo-
chromocytoma is proposed, but rarely can the diagnosis
really be pheochromocytoma. In one series of 300 cases,
only one patient had pheochromocytoma [11]. On the
other hand, the proportion of malignant pheochromocy-
toma cases is 2.5–14 %, and these findings are diagnosed
with metastases or local invasion [3].
The literature states that incidental pheochromocytoma
cases that are smaller than 1 cm have no clinic symptoms
[12]. Rarely, some large pheochromocytoma cases do not
show any clinical symptoms [13]. It is difficult to diag-
nose very small ones. Pheochromocytoma can be diag-
Pathologic view Figure 3
Pathologic view. Stain: (H&E). Magnification: ×40.Cases Journal 2008, 1:10 http://www.casesjournal.com/content/1/1/10
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nosed during investigation of other diseases or adrenal
incidentaloma. One line of research from the Mayo Clinic
shows that 15 of the 150 pheochromocytoma cases are
diagnosed during abdominal CT taken for other reasons
[10]. One of the important signs of silent pheochromocy-
tomas is the occurrence of hypertension attacks during
surgery or anesthesia [14]. Our case showed no hyperten-
sion or hypertension attacks in his history. Physical exam-
ination revealed no hypertension-related symptoms.
Furthermore, he did not have any complaints except epi-
gastric bloating. Additionally, there were no abnormali-
ties in ecocardiography or the ECG. Consequently,
pheochromocytoma was not considered.
Pheochromocytoma can be diagnosed by establishing the
increase of catecholamines and metabolites in the plasma
and urine. The level of catecholamines and metabolites in
the plasma and urine provides 95 % of the evidence for
the disease. Free catecholamines (epinephrine or nore-
pinephrine) or metabolites (metanephrine, normetane-
phrine, or VMA) can be measured in the urine, and the
levels of metanephrine or catecholamines can be meas-
ured from the plasma. Measurement of metanephrine in
the urine is the most useful test [14]. If the level of cate-
cholamines in the urine 2 or 3 times as high as normal, a
pheochromocytoma may be present. There was no excess
of catecholamines in the plasma or urine in our case.
The dimension of the mass was > 3 cm but the HU was up
to 40 HU. Our patient underwent surrenalectomy even
though there was no incidental pheochromocytoma. Lab-
oratory findings support the absence of a pheochromocy-
toma. Since the operation material of the patient showed
some findings related to pheochromocytoma, the patient
was scanned for multiple endocronological neoplasias
(MEN) in the postoperative period. Calcitonin and PTH
levels detected for screening MEN. No clinical or diagnos-
tical findings have been observed.
All incidental adrenal cases must be examined very care-
fully, because the chance of mortality is high when they
are not diagnosed. Incidental pheochromocytoma cases
have nonhomogenic, cystic, and hemoragic images in
screening methods. Because our case was homogeneous,
we did not consider pheochromocytoma as a diagnosis
for our case. The image of a bilateral surrenal incidental
lesion is one of the most important symptoms of pheo-
chromocytoma. The image of the left adrenal was normal
in our case.
Conclusion
During the laboratory investigation, there was no evi-
dence of abnormalities. We, therefore, conclude that these
cases can be regarded as sublaboratory pheochromocyto-
mas. However, further studies of more cases must be done
to clarify this subject.
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